Rights Issue Placement

Costain Group PLC 14 September 2007 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, CANADA, FRANCE, JAPAN, MALAYSIA, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE 14 September 2007 Costain Group PLC Rights Issue - Successful Placement of RIGHTS OVER NEW ORDINARY SHARES Following Costain Group PLC's ('Costain') announcement earlier today relating to the issue of 267,923,469 new ordinary shares (the 'New Ordinary Shares') under a 3 for 4 rights issue (the 'Rights Issue'), Costain announces that Daedalus Projects Limited ('Daedalus'), has agreed, conditional inter alia on the admission of the New Ordinary Shares, nil paid, to the Official List and to trading on the main market for listed securities of the London Stock Exchange, to sell rights over 81,261,941 New Ordinary Shares ('Daedalus Rights'), representing 30.3% of the New Ordinary Shares issuable under the Rights Issue, to Dresdner Kleinwort Securities Limited ('Dresdner') at 3.7857p per Daedalus Right to raise £3.1 million. Daedalus will use these proceeds to fund the take up of its remaining entitlement to subscribe for 12,753,964 New Ordinary Shares at the issue price of 24p under the terms of the Rights Issue. Dresdner has agreed to pay the 24p call on, and take up, the 81,261,941 Daedalus Rights in full and sell 45,681,941 of such rights, fully paid, to Arbuthnot Securities Limited at 27.7857p per Daedalus Right. With the exception of a small number of rights reserved for market making purposes, Dresdner and Arbuthnot have placed all of the fully paid Daedalus Rights with investors. Prior to the Rights Issue, Daedalus held 35.1 per cent. of Costain's issued ordinary share capital. Following the Rights Issue Daedalus is expected to hold 22.1 per cent. of the enlarged issued ordinary share capital. Contacts: Costain Group PLC Tel: 020 7705 8444 Andrew Wyllie, Group Chief Executive Tony Bickerstaff, Group Finance Director Hawkpoint Partners Limited (Financial adviser and Sponsor) Tel: 020 7665 4500 Christopher Kemball Chris Robinson Arbuthnot Securities Limited (Joint broker to Costain) Tel: 020 7012 2000 James Steel Richard Dunn Dresdner Kleinwort Limited (Joint broker to Costain) Tel: 020 7623 8000 Charles Batten Michael Covington College Hill (PR advisers) Tel: 020 7457 2020 Mark Garraway Matthew Gregorowski Hawkpoint Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as financial adviser and sponsor to Costain and is acting for no one else in connection with the Rights Issue and will not be responsible to anyone other than Costain for providing the protections afforded to clients of Hawkpoint Partners Limited, nor for providing advice in connection to the Rights Issue or any other matter referred to herein. Arbuthnot Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Costain and for no one else in connection with matters described in this announcement and is not advising any other person or treating any other person as its client in relation to matters described in this announcement and will not be responsible to anyone other than Costain for providing the protections afforded to clients of Arbuthnot Securities Limited, or for giving advice to any other person in relation to the contents of this announcement or any other matter referred to in this announcement. Dresdner Kleinwort Securities Limited, which is authorised and regulated by the Financial Services Authority, is acting for Costain and for no one else in connection with the matters described in this announcement and will not be responsible to anyone other than Costain for providing the protections afforded to customers of Dresdner Kleinwort Securities Limited, or for affording advice in relation to the contents of this announcement or any other matter referred to herein. This announcement does not constitute an offer to sell or the solicitation of an offer to acquire or subscribe for New Ordinary Shares. The offer to acquire New Ordinary Shares pursuant to the proposed Rights Issue will be made solely on the basis of the information contained in the Prospectus. This announcement is not an offer of securities for sale in, into or from the United States, Canada, France, Japan, Malaysia, New Zealand, South Africa or Switzerland. The New Ordinary Shares have not been and will not be registered under the US Securities Act of 1933 (as amended) or under any relevant securities laws of any state or other jurisdiction of the United States, and will not qualify for distribution under any of the relevant securities laws of Canada, France, Japan, Malaysia, New Zealand, South Africa or Switzerland. Accordingly, the New Ordinary Shares may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States (absent registration or an applicable exemption from registration) or within Canada, France, Japan, Malaysia, New Zealand, South Africa or Switzerland.. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings